Alterations in gene expression profiles during prostate cancer progression: Functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors

Cancer Research

Volumn 62, Issue 18, 2002, Pages 5325-5335

  Calvo, Alfonso ^a   Xiao, Nianqing ^a   Kang, Jason ^a   Best, Carolyn J M ^a   Leiva, Isabel ^a   Emmert Buck, Michael R ^a   Jorcyk, Cheryl ^b   Green, Jeffrey E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BOISE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENTARY DNA; ONCOPROTEIN; PROTEIN MTA2; PROTEIN TROP2; RAB PROTEIN; RAB25 PROTEIN; SELENIUM; SELENOPROTEIN; SELENOPROTEIN P; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CARCINOGENICITY; CELL ADHESION; CELL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DNA FINGERPRINTING; DNA MICROARRAY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; MALE; METASTASIS ASSOCIATED GENE 2; METASTASIS POTENTIAL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CELL ADHESION MOLECULES; CELL DIVISION; CLUSTER ANALYSIS; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELENOPROTEIN P; SELENOPROTEINS; TUMOR CELLS, CULTURED;

EID: 0037105740     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Cancer Statistics, 2001
2. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients
3. Epidemiology of prostatic cancer
4. A critical evaluation of the application of biomarkers in epidemiological studies on diet and health
5. Regulation of prostatic growth and function by peptide growth factors
6. Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells
7. Molecular genetics of prostate cancer
8. 2-Difluoromethylomithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice
9. Chemoprevention of prostate carcinogenesis by α-difluoromethylornithine in TRAMP mice
10. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene
11. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: Histopathological and molecular biological alterations
12. Development and characterization of a mouse prostate adenocarcinoma cell line: Ductal formation determined by extracellular matrix
13. Development of PIN and prostate adenocarcinoma cell lines: A model system for multistage tumor progression
14. Growth responses of normal, benign hyperplastic, and malignant human prostatic epithelial cells in vitro to cholera toxin, pituitary extract, and hydrocortisone
15. Initiating oncogenic event determines gene expression patterns of human breast cancer models
16. Loss of annexin II heavy and light chains in prostate cancer and its precursors
17. ANX7, a candidate tumor suppressor gene for prostate cancer
18. Co-down-regulation of cell adhesion proteins α- and β-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas
19. E-, N-, and P-cadherin and α-, β- and γ-catenin protein expression in normal hyperplastic, and carcinomatous human prostate
20. Htert expression correlates with MYC overexpression in human prostate cancer
21. Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer
22. Insulin-like growth factor 1 (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer
23. Metallothionein isoform 1 and 2 gene expression in the human prostate: Down-regulation of MT-1X in advanced prostate cancer
24. Localization and quantification of mRNA for matrixmetalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue
25. The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy
26. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue
27. Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma
28. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer
29. The cadherin cell-cell adhesion pathway in prostate cancer progression
30. Tumor-suppressive activity of CD66a in prostate cancer
31. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone
32. Expression of the insulin-like growth factor system and cancer progression in hormone-treated prostate cancer patients
33. Selenium, selenoproteins, and human health: A review
34. Human cell lines as an in vitrolin vivo model for prostate carcinogenesis and progression
35. Annexin 2 has an essential role in actin-based macropinocytic rocketing
36. Expression and characterization of a Dictyostelium discoideum annexin
37. Characterization of mouse metastasis-associated gene 2: Genomic structure, nuclear localization signal, and alternative potentials as transcriptional activator and repressor
38. Involvement of integrin α(v)β(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells
39. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial
40. Selenoprotein P
41. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-κB activation
42. Liver necrosis and lipid peroxidation in the rat as the result of paraquat and diquat administration. Effect of selenium deficiency
43. Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: Assessment of the roles of lipid peroxidation and selenoprotein P